Skip to navigation Skip to content

Share

Master Page Does Not Exist

    Services

    Master Page Does Not Exist
    1. Study to Compare the Efficacy and Safety of Fingolimod with Glatiramer Acetate

      Clinical Trial: A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis.

      Multiple Dates
    2. Talk to an MS Navigator

      The Society's MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or see "More info" to contact us online.

    3. Clinical Trials In Your Area

      Interested in clinical trial near you? Simply search by state, type of MS or keyword and see what’s going on in your area.

      Multiple Dates
    4. Surveys and Other Research Studies

      View a list of surveys (mostly online) and other research studies seeking to recruit people with MS.

      Multiple Dates
    5. Evergreen Health: Measuring the Impact of Tecfidera on the Gut Microbiota

      Clinical Trial: Measuring the Impact of Tecfidera on the Gut Microbiota: Does a Change in the Gut Flora Correlate with Gastrointestinal Disturbances Following Therapy Initiation?

      Multiple Dates
      Kirkland, WA
    6. Evergreen Healthcare: Pilot study of (MIRROR)

      Clinical Trial: Pilot study of Mirabegron and behavioral modification including pelvic floor exercise for overactive bladder in multiple sclerosis (MIRROR)

      Multiple Dates
      Kirkland, WA
    7. Virginia Mason: ASSESS

      Clinical Trial: A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis

      Multiple Dates
      Seattle, WA
    8. Virginia Mason: Alkermes01

      Clinical Trial: A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis

      Multiple Dates
      Seattle, WA
    9. Virginia Mason: Ofatumab

      Clinical Trial: A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis

      Multiple Dates
      Seattle, WA
    10. Swedish - An Intravenous Infusion Study of rHIgM22

      This is a Phase 1, multi-center, double-blind, randomized, placebo-controlled, dose-escalation study in subjects with relapsing Multiple Sclerosis(MS).The primary outcome will be safety and tolerability of a single dose of rHIgM22.

      Seattle, WA 98122See Map
    11. Swedish - An Intravenous Infusion Study of rHIgM22

      The primary objective of this expanded access program is to provide ocrelizumab as treatment for eligible participants with primary progressive multiple sclerosis (PPMS) before FDA approval.

      Seattle, WA 98122See Map

    Resources

    Master Page Does Not Exist
    1. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    2. Clinical Trials: Solving One Piece of the MS Puzzle Part 1 (video)

      This video features part one of a series that discusses research efforts for multiple sclerosis and clinical trials.

    3. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    4. Find Clinical Trials

      Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

    5. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    6. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    7. Veterans with Multiple Sclerosis

      The National MS Society is collaborating with the Department of Veteran’s Affairs MS Centers of Excellence to support improved care and support services for veterans with multiple sclerosis and their families.

    8. "How the National MS Society Makes Funding Decisions" recorded teleconference

      Original Air Date: March 22, 2011 Presenter: Dr. Patricia O'Looney Research in MS is progressing at a remarkable rate, with more potential therapies in the pipeline than at any other time in history. The National MS Society is a driving force of MS research. Learn how far we've come, where we're going, and what the Society is doing to move toward a world free of MS.

    9. "MS Research Update" recorded teleconference

      Original Air Date: October 6, 2011

    10. MS Top 10 Therapies Research Update (Teleconference recording)

      During this teleconference participants will: Understand the risks and benefits of different treatment options; Learn about new treatments on the horizon; Understand how different treatment options compare to each other. The speaker, Dr. Graesser, specializes in MS and in addition to general neurology cases, she also provides care for movement disorders, headaches, and neurologic disorders in pregnancy.

    11. MS Research Using Vision (OCT) Testing: Anti-LINGO-1 (video)

      Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.

Share

Master Page Does Not Exist